Synedica Retatrutide Injection - Liquid, 1 Unit, 24 Months Shelf Life | Triple-hormone Receptor Agonist, Once-weekly Dosing, Advanced Glycemic Control, Weight Management, Enhanced Lipolysis, Appetite Suppression Price: 5900.00 INR (5000.00 INR + 18% GST) Get Latest Price MRP: 5900.00 INR / Box Weight : 40.00 Gram 1 Pack Contains : 10 Minimum Pack Size : 100 In Stock Product Specifications Product Overview Key Features Next-Gen Weight Management Advanced Glycemic Control Enhanced Lipolysis Activation Precision Subcutaneous Delivery Once-Weekly Dosing Schedule Metabolic Rate Optimization Clinical-Grade Purity Assurance Appetite Suppression Technology Cardiovascular Health Support Synedica Retatrutide is a breakthrough treatment designed to help patients achieve effective weight loss, improve blood sugar control, and support overall

GLP-1 Safety and Choosing the Right Option for Men The most common side effects with GLP-1 medications are gastrointestinal, such as nausea, bloating, constipation, or diarrhea, which are typically mild and improve as the body adjusts over time
keep away from the reach of the children
Discover why this innovative peptide is becoming a preferred choice for research relating to: Tri-agonist targeting GLP-1, GIP, and glucagon Weight management Insulin sensitivity and glucose control Metabolic efficiency Additional Information Retatrutide has shown promising results in human trials
Noinjecting in the same spot repeatedly increases risk of lipodystrophy, lumps, and reduced medication absorption
Overusing Albuterol increases the risk of adverse effects